Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity

Posted by

SELECTBIO

Vanessa Baeriswyl, Postdoc Researcher, EPFL

Abstract
We are generating bicyclic peptide ligands for disease targets using an approach based on phage display technology. The bicyclic peptides combine key qualities of antibody therapeutics (high affinity and specificity) and advantages of small molecule drugs.